201 related articles for article (PubMed ID: 3422828)
21. Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia.
Huang ME; Ye YC; Chen SR; Chai JR; Lu JX; Zhoa L; Gu LJ; Wang ZY
Blood; 1988 Aug; 72(2):567-72. PubMed ID: 3165295
[TBL] [Abstract][Full Text] [Related]
22. Identification of early relapsing patients with adult acute nonlymphocytic leukemia by bone marrow biopsy after initial induction chemotherapy.
Cassileth PA; Gerson SL; Bonner H; Neiman RS; Lusk EJ; Hurwitz S
J Clin Oncol; 1984 Feb; 2(2):107-11. PubMed ID: 6699661
[TBL] [Abstract][Full Text] [Related]
23. Intermediate-dose Ara-C/m-AMSA for remission induction and high-dose Ara-C/m-AMSA for intensive consolidation in relapsed and refractory adult acute myelogeneous leukemia.
Jehn U; Heinemann V
Haematol Blood Transfus; 1990; 33():333-8. PubMed ID: 1691134
[TBL] [Abstract][Full Text] [Related]
24. Probable in vivo induction of differentiation by retinoic acid of promyelocytes in acute promyelocytic leukaemia.
Nilsson B
Br J Haematol; 1984 Jul; 57(3):365-71. PubMed ID: 6589010
[TBL] [Abstract][Full Text] [Related]
25. Analysis of treatment failure in acute nonlymphocytic leukemia patients over fifty years of age. A Southwest Oncology Group study.
Ryan DH; Kopecky KJ; Head D; Grever MR; Shiaer SM; Lipschitz DA; Hynes HE; Vial RH; Veith RW; Gumbart CH
Am J Clin Oncol; 1992 Feb; 15(1):69-75. PubMed ID: 1550082
[TBL] [Abstract][Full Text] [Related]
26. Rebound peripheral blastosis with subsequent remission during remission induction in a patient with acute promyelocytic leukemia.
Amato R; Kantarjian H; Walters R; Keating M
Cancer; 1988 Feb; 61(4):650-3. PubMed ID: 3422175
[TBL] [Abstract][Full Text] [Related]
27. High-dose treatment with autologous bone marrow support as consolidation of first remission in younger patients with acute myelogenous leukaemia.
Rohatiner AZ; Bassan R; Raimondi R; Amess JA; Arnott S; Personen A; Rodeghiero F; Barbui T; Bradburn MJ; Carter M; Lister TA
Ann Oncol; 2000 Aug; 11(8):1007-15. PubMed ID: 11038038
[TBL] [Abstract][Full Text] [Related]
28. All-trans retinoic acid and low-dose cytosine arabinoside for the treatment of 'poor prognosis' acute myeloid leukemia.
Venditti A; Stasi R; Del Poeta G; Buccisano F; Aronica G; Bruno A; Pisani F; Caravita T; Masi M; Tribalto M
Leukemia; 1995 Jul; 9(7):1121-5. PubMed ID: 7630182
[TBL] [Abstract][Full Text] [Related]
29. Recombinant human granulocyte-macrophage colony-stimulating factor in combination with standard induction chemotherapy in de novo acute myeloid leukemia.
Bettelheim P; Valent P; Andreeff M; Tafuri A; Haimi J; Gorischek C; Muhm M; Sillaber C; Haas O; Vieder L
Blood; 1991 Feb; 77(4):700-11. PubMed ID: 1993213
[TBL] [Abstract][Full Text] [Related]
30. Short-term treatment for adult hypergranular and microgranular acute promyelocytic leukemia.
Bassan R; Battista R; Viero P; d'Emilio A; Buelli M; Montaldi A; Rambaldi A; Tremul L; Dini E; Barbui T
Leukemia; 1995 Feb; 9(2):238-43. PubMed ID: 7869758
[TBL] [Abstract][Full Text] [Related]
31. Adult patients with acute myeloid leukemia who achieve complete remission after 1 or 2 cycles of induction have a similar prognosis: a report on 1980 patients registered to 6 studies conducted by the Eastern Cooperative Oncology Group.
Rowe JM; Kim HT; Cassileth PA; Lazarus HM; Litzow MR; Wiernik PH; Tallman MS
Cancer; 2010 Nov; 116(21):5012-21. PubMed ID: 20629023
[TBL] [Abstract][Full Text] [Related]
32. [A case of acute nonlymphocytic leukemia with leukemic cell infiltration to the uterus followed by bone marrow relapse].
Shiga Y; Shichishima T; Aikawa K; Gotoh J; Furukawa T; Yamagiwa A; Ishibashi T; Maruyama Y
Rinsho Ketsueki; 1994 May; 35(5):501-5. PubMed ID: 8028198
[TBL] [Abstract][Full Text] [Related]
33. Allogeneic bone marrow transplantation in a program of intensive sequential chemotherapy for children and young adults with acute nonlymphocytic leukemia in first remission.
Dahl GV; Kalwinsky DK; Mirro J; Look AT; Pui CH; Murphy SB; Mason C; Ruggiero M; Schell M; Johnson FL
J Clin Oncol; 1990 Feb; 8(2):295-303. PubMed ID: 2299372
[TBL] [Abstract][Full Text] [Related]
34. [Intensive induction chemotherapy of adult acute myelogenous leukemia by continuing daunorubicin, behenoyl-cytosine arabinoside, 6-mercaptopurine and prednisolone until marrow aplasia].
Taguchi H; Kubonishi I; Takehara N; Uemura Y; Iwahara Y; Eguchi T; Miyagi T; Sugito S; Muneishi H; Tanaka Y
Gan To Kagaku Ryoho; 1992 Aug; 19(9):1309-14. PubMed ID: 1503485
[TBL] [Abstract][Full Text] [Related]
35. Primary therapy of acute promyelocytic leukemia: results of amsacrine- and daunorubicin-based therapy.
Arlin Z; Kempin S; Mertelsmann R; Gee T; Higgins C; Jhanwar S; Chaganti RS; Clarkson B
Blood; 1984 Jan; 63(1):211-2. PubMed ID: 6580926
[TBL] [Abstract][Full Text] [Related]
36. The unique aspects of acute promyelocytic leukemia.
Stone RM; Mayer RJ
J Clin Oncol; 1990 Nov; 8(11):1913-21. PubMed ID: 2230879
[TBL] [Abstract][Full Text] [Related]
37. The prognostic significance of myelonecrosis after induction therapy in acute leukemia.
Cassileth PA; Brooks JS
Cancer; 1987 Nov; 60(10):2363-5. PubMed ID: 3311345
[TBL] [Abstract][Full Text] [Related]
38. Short remission durations in therapy-related leukemia despite cytogenetic complete responses to high-dose cytarabine.
Larson RA; Wernli M; Le Beau MM; Daly KM; Pape LH; Rowley JD; Vardiman JW
Blood; 1988 Oct; 72(4):1333-9. PubMed ID: 3167210
[TBL] [Abstract][Full Text] [Related]
39. High-dose cytosine arabinoside and daunorubicin postremission therapy in adults with de novo acute myeloid leukemia. Long-term follow-up of a prospective multicenter trial.
Heil G; Mitrou PS; Hoelzer D; Freund M; Link H; Ehninger G; Steinke B; Ohl S; Wandt H; Fackler-Schwalbe E
Ann Hematol; 1995 Nov; 71(5):219-25. PubMed ID: 7492624
[TBL] [Abstract][Full Text] [Related]
40. Acute promyelocytic leukemia--clinical management of 15 patients.
Daly PA; Schiffer CA; Wiernik PH
Am J Hematol; 1980; 8(4):347-59. PubMed ID: 6932177
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
